We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Synthetic Biology Shows Promise to Cautious Public

By LabMedica International staff writers
Posted on 07 Oct 2010
Print article
Synthetic biology, defined as the design and construction of new biologic parts, devices, and systems or redesign of existing natural biologic systems for useful purposes, holds enormous potential to improve everything from medicine to energy production, with the global market projected to reach US$4.5 billion by 2015.

In regards to what the public knows about this emerging field, and what are their hopes and concerns, a new poll of 1,000 U.S. adults conducted by Hart Research Associates (Washington DC, USA) and the Synthetic Biology Project at the Woodrow Wilson Center (Washington DC, USA) found that two-thirds of Americans think that synthetic biology should move forward, but with more research to study its possible effects on humans and the environment, while one-third support a ban until we better understand its implications and risks. More than half of Americans believe the federal government should be involved in regulating synthetic biology.

"The survey clearly shows that much more attention needs to be paid to addressing biosafety and biosecurity risks,” said Dr. David Rejeski, director of the Synthetic Biology Project. "In addition, government and industry need to engage the public about the science and its applications, benefits, and risks.”

The poll findings reveal that the proportion of adults who reported they have heard a lot or some about synthetic biology has almost tripled in three years, (from 9 - 26%). By comparison, self-reported awareness of nanotechnology increased from 24 - 34% during the same three-year period.

Although the public supports continued research in the area of synthetic biology, it also harbors concerns, including 27% who have security concerns (i.e., that the science will be used to make harmful things), 25% who have moral concerns; and a similar amount who worry about negative health consequences for humans. A smaller portion, 13%, worries about possible damage to the environment.

"The survey shows that attitudes about synthetic biology are not clear-cut and that its application is an important factor in shaping public attitudes towards it,” said Geoff Garin, president of Hart Research. Six in 10 respondents support the use of synthetic biology to produce a flu vaccine. In contrast, three-fourths of those surveyed have concerns about its use to accelerate the growth of livestock to increase food production. Among those for whom moral issues are the top concern, the majority views both applications in a negative light.

The findings derive from a nationwide telephone survey of 1,000 adults and has a margin of error of ±3.1 percentage points. This is the fifth year that Hart Research Associates has conducted a survey to gauge public opinion about nanotechnology and/or synthetic biology for the Woodrow Wilson International Center for Scholars.

The Woodrow Wilson International Center for Scholars of the Smithsonian Institution was established by Congress in 1968. It is a nonpartisan institution, supported by public and private funds and engaged in the study of national and world affairs.

Related Links:
Hart Research Associates
Synthetic Biology Project at the Woodrow Wilson Center


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: ColoSense is the first FDA-approved RNA-based molecular screening test for qualitative detection of colorectal cancer (Photo courtesy of Geneoscopy)

RNA-Powered Molecular Test to Help Combat Early-Age Onset Colorectal Cancer

Colorectal cancer (CRC) ranks as the second most lethal cancer in the United States. Nevertheless, many Americans eligible for screening do not undergo testing due to limited access or reluctance towards... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more

Pathology

view channel
Image: The new method is quick and easy, and can also be used by non-medical personnel. (Photo courtesy of Zoratto et al. Advanced Science 2024, edited)

New Blood Test Device Modeled on Leeches to Help Diagnose Malaria

Many individuals have a fear of needles, making the experience of having blood drawn from their arm particularly distressing. An alternative method involves taking blood from the fingertip or earlobe,... Read more